Accomplishments in 2008 in the adjuvant treatment of colon cancer.
作者信息
Marshall John L, de Gramont Aimery, Köhne Claus-Henning, Marshall J L, de Gramont A, Köhne C-H
机构信息
Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
出版信息
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S2-7.
Abstract
Overview of the Disease IncidencePrognosisCurrent General Therapy Standards StagingLymph Node ExcisionStage III DiseaseStage II DiseaseMolecular MarkersAccomplishments During the Year Therapy Cytotoxic ChemotherapyChemotherapy Plus Targeted TherapySpecial PopulationsBasic Science-BiomarkersMethodologyWhat Needs to Be Done Application of the AccomplishmentsControversies and DisagreementsFuture Directions Comments on ResearchObstacles to Progress.
摘要
相似文献
1
Accomplishments in 2008 in the adjuvant treatment of colon cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S2-7.
2
Accomplishments in 2007 in the adjuvant treatment of colorectal cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S2-6.
3
Accomplishments in 2007 in the management of localized pancreatic cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S32-6.
4
Accomplishments in 2007 in the management of curable metastatic colorectal cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S13-8.
5
Accomplishments in 2007 in the management of localized gastric cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S42-6.
6
Accomplishments in 2007 in the adjuvant treatment of rectal cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S7-S12.
7
Accomplishments in 2008 in the management of localized pancreatic cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S37-42.
8
Accomplishments in 2007 in the management of advanced gastroesophageal cancer.
Gastrointest Cancer Res. 2008 May;2(3 Suppl):S47-50.
9
Accomplishments in 2008 in the management of advanced gastroesophageal cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S58-61.
10
Accomplishments in 2008 in the management of curable metastatic colorectal cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S15-22.
引用本文的文献
1
Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.
Epidemiology. 2015 Sep;26(5):690-9. doi: 10.1097/EDE.0000000000000355.
本文引用的文献
1
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.
J Clin Oncol. 2013 Jul 10;31(20):2600-6. doi: 10.1200/JCO.2013.49.6638. Epub 2013 Jun 3.
2
Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.
J Clin Oncol. 2010 Jan 20;28(3):460-5. doi: 10.1200/JCO.2009.23.1407. Epub 2009 Dec 14.
3
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
J Clin Oncol. 2009 Jul 1;27(19):3109-16. doi: 10.1200/JCO.2008.20.6771. Epub 2009 May 18.
4
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
J Clin Oncol. 2009 Jul 10;27(20):3385-90. doi: 10.1200/JCO.2009.21.9220. Epub 2009 May 4.
5
Cancer statistics, 2008.
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
6
Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
J Clin Oncol. 2007 Aug 20;25(24):3732-8. doi: 10.1200/JCO.2007.12.2234.
7
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
J Clin Oncol. 2007 Aug 10;25(23):3456-61. doi: 10.1200/JCO.2007.11.2144.
8
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
J Clin Oncol. 2007 Jun 1;25(16):2198-204. doi: 10.1200/JCO.2006.08.2974. Epub 2007 Apr 30.
9
Lymph node evaluation and survival after curative resection of colon cancer: systematic review.
J Natl Cancer Inst. 2007 Mar 21;99(6):433-41. doi: 10.1093/jnci/djk092.
10
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
J Clin Oncol. 2006 Nov 20;24(33):5313-27. doi: 10.1200/JCO.2006.08.2644. Epub 2006 Oct 23.
Zotero 插件